Company Filing History:
Years Active: 2018-2024
Title: Mubashir Javed Mintoo: Innovator in Anticancer Solutions
Introduction
Mubashir Javed Mintoo is a notable inventor based in Jammu, India, recognized for his valuable contributions to the field of cancer treatment. With three patents to his name, he is making significant strides in developing more effective therapeutic solutions.
Latest Patents
Mubashir's most recent innovations include groundbreaking patents for anticancer compounds. The first patent is titled "Solid dispersion comprising an anticancer compound for improved solubility and efficacy." This invention focuses on novel solid dispersion formulations that enhance the dissolution and in-vivo activity of a specific anticancer compound. The formulation combines the compound with a hydrophilic polymer, offering a promising approach to treat various types of cancer effectively.
His second patent, "Fused pyrimidines as isoform selective phosphoinositide-3-kinase-alpha inhibitors and process for preparation thereof," delves into the medicinal use of fused pyrimidines. This innovation presents isoform selective PI3Kα inhibition, showcasing a new avenue for the development of anticancer agents.
Career Highlights
Mubashir Javed Mintoo is affiliated with the Council of Scientific & Industrial Research (CSIR), where he continues to engage in innovative research. His work primarily focuses on enhancing cancer therapies, aiming to improve patient outcomes through better pharmaceutical formulations.
Collaborations
Throughout his career, Mubashir has collaborated with esteemed colleagues such as Ram Asrey Vishwakarma and Sandip Bibishan Bharate. These collaborations have fostered a conducive environment for innovation and have been instrumental in the development of his significant patents in cancer research.
Conclusion
Mubashir Javed Mintoo stands out as a dedicated inventor in the field of cancer research. His pioneering work, particularly in the development of effective anticancer formulations, reflects his commitment to advancing medical science. With continued innovation and collaboration, he is poised to make even greater contributions to the healthcare industry in the future.